Wuhan Aiweige

Wuhan Aiweige Biotechnology is a specialized life sciences company headquartered in the Wuhan National Bio-industry Park (Biolake), China. Established in 2016, the firm focuses on the research, development, and commercialization of essential biological reagents, including recombinant proteins, antibodies, and ELISA kits. Beyond its product portfolio, the company operates as a contract research organization (CRO), offering technical services in protein expression, antibody preparation, and molecular biology. Wuhan Aiweige supports global researchers in fields such as oncology, immunology, and cell biology by providing high-purity reagents and customized laboratory solutions. The company's infrastructure is designed to meet the rigorous demands of both academic research and industrial drug discovery workflows. Its commitment to quality and technical support has established it as a reliable partner for the life sciences community.